DE69735497D1 - Medizinische aerosolformulierungen enthaltend budesonide - Google Patents

Medizinische aerosolformulierungen enthaltend budesonide

Info

Publication number
DE69735497D1
DE69735497D1 DE69735497T DE69735497T DE69735497D1 DE 69735497 D1 DE69735497 D1 DE 69735497D1 DE 69735497 T DE69735497 T DE 69735497T DE 69735497 T DE69735497 T DE 69735497T DE 69735497 D1 DE69735497 D1 DE 69735497D1
Authority
DE
Germany
Prior art keywords
budesonides
aerosol formulations
formulations contained
medical aerosol
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69735497T
Other languages
English (en)
Other versions
DE69735497T2 (de
Inventor
Nayna Govind
A Jinks
L Ross
H Ward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Co
Original Assignee
Minnesota Mining and Manufacturing Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10800599&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69735497(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co
Publication of DE69735497D1 publication Critical patent/DE69735497D1/de
Application granted granted Critical
Publication of DE69735497T2 publication Critical patent/DE69735497T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69735497T 1996-09-27 1997-09-23 Medizinische aerosolformulierungen enthaltend budesonid Expired - Lifetime DE69735497T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9620187.6A GB9620187D0 (en) 1996-09-27 1996-09-27 Medicinal aerosol formulations
GB9620187 1996-09-27
PCT/US1997/016869 WO1998013031A2 (en) 1996-09-27 1997-09-23 Medicinal aerosol formulations comprising budesonide

Publications (2)

Publication Number Publication Date
DE69735497D1 true DE69735497D1 (de) 2006-05-11
DE69735497T2 DE69735497T2 (de) 2006-08-24

Family

ID=10800599

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69735497T Expired - Lifetime DE69735497T2 (de) 1996-09-27 1997-09-23 Medizinische aerosolformulierungen enthaltend budesonid

Country Status (21)

Country Link
EP (1) EP0932397B2 (de)
JP (1) JP2001501209A (de)
KR (1) KR20000048646A (de)
AR (1) AR009370A1 (de)
AT (1) ATE320246T1 (de)
AU (1) AU732985B2 (de)
BR (1) BR9712125A (de)
CA (1) CA2266431A1 (de)
CZ (1) CZ102799A3 (de)
DE (1) DE69735497T2 (de)
ES (1) ES2259447T3 (de)
GB (1) GB9620187D0 (de)
HU (1) HUP0000795A3 (de)
ID (1) ID22523A (de)
MY (1) MY130946A (de)
NO (1) NO991407L (de)
PL (1) PL332422A1 (de)
PT (1) PT932397E (de)
SK (1) SK38399A3 (de)
WO (1) WO1998013031A2 (de)
ZA (1) ZA978303B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863910A (en) * 1996-01-12 1999-01-26 Bolonick; Joel Treatment of chronic inflammatory disorders of the gastrointestinal tract
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
GB9925934D0 (en) * 1999-11-03 1999-12-29 Glaxo Group Ltd Novel apparatus and process
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
JP5392880B2 (ja) 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
SI1273292T1 (en) 2001-07-02 2004-12-31 Chiesi Farmaceutici S.P.A. Optimised formulation of tobramycin for aerosolization
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
GB0311701D0 (en) * 2003-05-21 2003-06-25 Karib Kemi Pharm Liited Improved metered dose inhaler product
EP1595531A1 (de) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stabile Arzneimittellösung für Druckdosierinhalatoren
EP1949891A1 (de) * 2004-10-12 2008-07-30 Generics (UK) Limited Verfahren zur Herstellung von Suspensionsaerosolformulierungen, wobei die Partikel durch Fällung im Innenkanister gebildet werden
US9808423B2 (en) 2004-10-12 2017-11-07 Generics [Uk] Limited Preparation of suspension aerosol formulations
ES2259915B1 (es) * 2005-03-15 2007-12-16 Laboratorio Aldo-Union, S.A. Nueva formulacion estable de aerosoles en suspension y procedimiento de obtencion.
TW201010708A (en) * 2008-06-02 2010-03-16 Intervet Int Bv Composition comprising an antibiotic and a corticosteroid
CN103655473A (zh) * 2011-10-27 2014-03-26 江苏长风药业有限公司 以氢氟烷烃为抛射剂的布地奈德气雾剂制剂
CN102362859A (zh) * 2011-10-27 2012-02-29 江阴长风医药科技有限公司 以氢氟烷烃为抛射剂的布地奈德气雾剂制剂
CN109646400A (zh) * 2018-12-25 2019-04-19 上海信谊百路达药业有限公司 一种布地奈德吸入气雾剂及其制备方法
CN112891328A (zh) * 2021-04-12 2021-06-04 上海方予健康医药科技有限公司 一种吸入用布地奈德混悬液的制备方法
CN113768906B (zh) * 2021-10-25 2023-05-09 上海方予健康医药科技有限公司 新型糖皮质激素吸入气雾剂及药物组件

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) † 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
US5136107A (en) * 1990-06-04 1992-08-04 Ethyl Corporation Process for halogenating aromatic compounds
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
WO1993011747A1 (en) † 1991-12-18 1993-06-24 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
DE4230876A1 (de) † 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
CA2156408C (en) * 1993-03-17 2005-02-15 Daniel C. Duan Aerosol formulation containing a polyester dispersing aid
DE4322703A1 (de) * 1993-07-08 1995-01-12 Asta Medica Ag Druckgaspackungen unter Verwendung von Polyoxyethylen-glyceryl-fettsäureestern als Suspensionsstabilisatoren und Ventilschmiermittel
TW283164B (de) * 1993-09-24 1996-08-11 Du Pont
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
GB9425160D0 (en) † 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
BR9510510A (pt) * 1994-12-22 1998-07-07 Astra Ab Formulação em aerossol farmacêutica uso da mesma e processos para fabricação da mesma para tratamento de um paciente carente de terapia

Also Published As

Publication number Publication date
EP0932397A2 (de) 1999-08-04
MY130946A (en) 2007-07-31
AR009370A1 (es) 2000-04-12
DE69735497T2 (de) 2006-08-24
PT932397E (pt) 2006-07-31
NO991407D0 (no) 1999-03-23
BR9712125A (pt) 1999-08-31
AU4492697A (en) 1998-04-17
HUP0000795A2 (hu) 2000-08-28
GB9620187D0 (en) 1996-11-13
KR20000048646A (ko) 2000-07-25
ATE320246T1 (de) 2006-04-15
ID22523A (id) 1999-10-28
CA2266431A1 (en) 1998-04-02
ES2259447T3 (es) 2006-10-01
SK38399A3 (en) 1999-09-10
CZ102799A3 (cs) 1999-07-14
JP2001501209A (ja) 2001-01-30
WO1998013031A3 (en) 1998-08-27
AU732985B2 (en) 2001-05-03
HUP0000795A3 (en) 2000-09-28
EP0932397B2 (de) 2014-04-02
EP0932397B1 (de) 2006-03-15
PL332422A1 (en) 1999-09-13
ZA978303B (en) 1999-03-15
WO1998013031A2 (en) 1998-04-02
NO991407L (no) 1999-03-23

Similar Documents

Publication Publication Date Title
DE69735497D1 (de) Medizinische aerosolformulierungen enthaltend budesonide
DE69730723D1 (de) Medizinische aerosolformulierungen von formoterol
ATE236617T1 (de) Aerosol-arzneiformulierungen
IT1293803B1 (it) Formulazioni di aerosol medicinali
DE69738755D1 (de) Sofort auflösbare medizinische zusammenstellung
PT101722A (pt) Formulacoes de analogo de insuluna
DE69021387T2 (de) Medizinische aerosolformulierungen.
DE69727329D1 (de) Medizinische Elektrode
EE9900031A (et) Tramadooli mitmikühikulised preparaadid
NO944526D0 (no) Medisinsk aerosolformulering
BR9710110A (pt) Novas formulações de inseticidas
ID16781A (id) Formulasi-formulasi farmasi
NO990956D0 (no) Klorfluorkarbonfrie mometasonfuroataerosolpreparater
ITMI941169A0 (it) Formulazioni farmaceutiche
DE29700307U1 (de) Zerstäuber für medizinische Zwecke
NO991430L (no) Insektfordrivende formuleringer
DE59702387D1 (de) Medizinische zange
SE9404469D0 (sv) Aerosol formulations
DE29702436U1 (de) Fußschalter
DE29613199U1 (de) Medizinisches Inhaliergerät
BR7601915U (pt) Palmilha antisséptica universal
SE9502452D0 (sv) Aerosol formulations
DE9400118U1 (de) Medizinische Zange
KR970053195U (ko) 일회용 성냥갑
SE9404467D0 (sv) Drug formulations

Legal Events

Date Code Title Description
8363 Opposition against the patent